Journal of Clinical Medicine (Apr 2023)

Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)

  • Dorian Culié,
  • Renaud Schiappa,
  • Tanguy Pace-Loscos,
  • Bruno Guelfucci,
  • Sebastien Vergez,
  • Renaud Garrel,
  • Nicolas Fakhry,
  • Olivier Dassonville,
  • Gilles Poissonnet,
  • Benjamin Lallemant,
  • Anne Sudaka,
  • Esma Saada-Bouzid,
  • Karen Benezery,
  • Stephane Temam,
  • Phillipe Gorphe,
  • Emmanuel Chamorey,
  • Alexandre Bozec

DOI
https://doi.org/10.3390/jcm12093169
Journal volume & issue
Vol. 12, no. 9
p. 3169

Abstract

Read online

Nutritional support during radiotherapy is crucial to tolerating and completing oropharyngeal squamous cell carcinoma (OPSCC) treatment. The impact of HPV status on nutritional support is debated. The objective was to evaluate the rate of Reactive Feeding Tube (RFT) use and determine its prognostic factors during definitive radiotherapy for OPSCC. All OPSCC patients treated from 2009 to 2014 were included in this multicentric retrospective study. The impact of tumor p16 status on the risk of RFT was assessed through multivariate analyses. Among the 543 patients, 103 patients required an RFT (19.0%). The use of RFT differed between centers (5% to 32.4%). In multivariate analysis, only tongue base involvement and concurrent chemotherapy were significantly associated with RFT (OR = 2.18 and 3.7, respectively). Tongue base involvement and concomitant chemotherapy were prognostic factors for RFT. HPV status was not a prognostic factor for enteral nutrition during radiotherapy for OPSCC.

Keywords